NSLI
GILD icon

Nan Shan Life Insurance’s Gilead Sciences GILD Stock Holding History

Nan Shan Life Insurance’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.5M Hold
82,838
– – 0.42% 57
2025
Q4 		$10.2M Sell
82,838
-295,568
-78% -$35.9M 0.31% 58
2025
Q3 		$42M Buy
378,406
+220,417
+140% +$25.1M 0.89% 36
2025
Q2 		$17.5M Buy
+157,989
New +$16.8M 0.39% 76
2025
Q1 		– Sell
-243,792
Closed -$22.5M – 116
2024
Q4 		$22.5M Sell
243,792
-492,590
-67% -$44.4M 0.54% 62
2024
Q3 		$61.7M Buy
736,382
+96,032
+15% +$7.33M 1.45% 20
2024
Q2 		$43.9M Buy
640,350
+73,046
+13% +$4.87M 1.04% 32
2024
Q1 		$41.6M Buy
567,304
+280,288
+98% +$21.6M 0.98% 36
2023
Q4 		$23.3M Sell
287,016
-324,700
-53% -$25.3M 0.56% 57
2023
Q3 		$45.8M Buy
611,716
+196,309
+47% +$15.1M 1.25% 26
2023
Q2 		$32M Buy
415,407
+111,607
+37% +$8.9M 0.77% 45
2023
Q1 		$25.2M Buy
303,800
+245,992
+426% +$20.4M 0.6% 55
2022
Q4 		$4.96M Sell
57,808
-763,884
-93% -$60.5M 0.14% 79
2022
Q3 		$50.7M Hold
821,692
– – 1.24% 23
2022
Q2 		$50.8M Buy
821,692
+147,508
+22% +$9.13M 1.07% 29
2022
Q1 		$40.1M Buy
+674,184
New +$43.1M 0.7% 48
2021
Q2 		– Sell
-139,209
Closed -$9M – 112
2021
Q1 		$9M Hold
139,209
– – 0.17% 100
2020
Q4 		$8.11M Buy
+139,209
New +$8.4M 0.17% 98
2020
Q2 		– Sell
-220,776
Closed -$16.5M – 111
2020
Q1 		$16.5M Buy
220,776
+60,776
+38% +$4.2M 0.6% 48
2019
Q4 		$10.4M Buy
+160,000
New +$10.4M 0.32% 55

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Nan Shan Life Insurance's GILD Position: Q1 2026 in Review

Nan Shan Life Insurance held its Gilead Sciences (GILD) position steady in Q1 2026 at 82,838 shares worth $11.5M. The position accounts for 0.42% of the portfolio, ranked #57.

Nan Shan Life Insurance first reported a position in GILD in Q4 2019 and has held it in 20 quarters since. The position peaked at $61.7M in Q3 2024. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Nan Shan Life Insurance held 82,838 shares of Gilead Sciences worth $11.5M as of Q1 2026.
  • Nan Shan Life Insurance left its Gilead Sciences share count unchanged in Q1 2026.
  • Gilead Sciences made up 0.42% of Nan Shan Life Insurance's portfolio in Q1 2026, its #57 holding.
  • Nan Shan Life Insurance first reported a position in Gilead Sciences in Q4 2019 and has held it in 20 quarters since.
  • Nan Shan Life Insurance's Gilead Sciences position peaked at $61.7M in Q3 2024.
  • 2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Nan Shan Life Insurance's 13F filing for Q1 2026, filed 14 May 2026.